Research scientist Li Zhu works in the lab at Halozyme Inc., which is developing drugs that target cancer.

Research scientist Li Zhu works in the lab at Halozyme Inc., which is developing drugs that target cancer. Photo by Melissa Jacobs.

— In today’s market, with valuations down and investors wary, it’s critical for biotechs to get creative when looking for cash to fuel research...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • NEW: San Diego 500 — influential business leaders you need to know
Yours for only $129